Coronavirus, COVID-19 & Clinical Research: an overview

Last updated: 31 March 2020, 2:58 AM (CET)
The overview below originates from the ‘Nieuwsbrief voor Goede Onderzoekspraktijken (#110, 15 March 2020)‘ (translation: Newsletter for Good Research Practices) and supplemented by information that has since become available on the internet. As developments regarding COVID quickly follow, the content of this page may be outdated tomorrow. As soon as new information is available it will be added to this page.

If there are important links missing, or if you have found any broken links, please contact me by using the contact form. In the case of important developments for the Netherlands, I will share them with my subscribers via a separate notification message. More information, click here (in Dutch).

Do you have any additions or suggestions? Send an email to

Onderstaand overzicht is overgenomen uit de ‘Nieuwsbrief voor Goede Onderzoekspraktijken‘nr. 110 van 15 maart 2020 en aangevuld met informatie die ondertussen beschikbaar is gekomen op internet. Het betreft uiteraard een tijdsopname en informatie kan morgen alweer achterhaald zijn. Zodra er nieuwe informatie beschikbaar is zal deze worden toegevoegd aan deze pagina.

Als u belangrijke informatie en/of verwijzing mist dan kunt u die met mij delen via het contact formulier. Mochten er voor Nederland belangrijke ontwikkelingen zijn dan zal ik dat met mijn abonnees delen via een apart notificatie bericht. Meer informatie, klik hier.

Heeft u een aanvulling of suggesties? Stuur een e-mail naar

Ook interessant: ‘Gezien bij Op1: Paul Elbers over de inzet van AI tegen COVID-19‘ en ‘Voor Nederland bruikbare guidance voor mensgebonden onderzoek in verband met COVID-19‘.


Missing important links or found any broken links? Please use this form to report broken/missing links.

Public consultations

European Medicines Agency

  • Points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials
    Consultation dates: 25 March 2020 to 25 April 2020
    Click here to download

European Union & Global


European Centre for Disease Prevention and Control

European Commission

European Council

European Data Protection Board

European Data Protection Supervisor

European Medicines Agency

European Network for Health Technology Assessment (EUnetHTA)

European Network of Centres for Pharmacoepidemiology and Pharmacovigilance

EMA and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) encouraged all researchers to register their pharmacoepidemiological studies related to the COVID-19 pandemic in the EU PAS Register. They should also upload and make their study protocols public, with a description of the data collected or planned to be collected. This is to facilitate collaborations and speed up the design of observational studies by others. Researchers should include ‘COVID-19’ in the study title to allow easy retrieval of all COVID-19-related studies via the ‘Title of Study’ search filter.
– Bron: EMA

Heads of Medicines Agencies

International Coalition of Medicines Regulatory Authorities (ICMRA)

A virtual meeting, held under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), convening experts from medicines regulatory authorities, the World Health Organisation (WHO) and the European Commission.

World Health Organization

Missing important links or found any broken links? Please use this form to report broken/missing links.

Countries & EU Member States







Czech Republic


Denmark (via Jon I. Bergsteinsson)







Ireland (via John Hutchinson)

Italy (via Jon I. Bergsteinsson)







South Africa

Slovakia (via John Hutchinson)




United Kingdom

United States

FDA recognizes that the COVID-19 pandemic may impact the conduct of clinical trials of medical products. Challenges may arise, for example, from quarantines, site closures, travel limitations, interruptions to the supply chain for the investigational product, or other considerations if site personnel or trial subjects become infected with COVID-19. FDA has issued guidance for industry, investigators, and IRBs. The guidance is intended to provide general considerations to assist in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.
– FDA, 18 March 2020

Missing important links or found any broken links? Please use this form to report broken/missing links.

Organizations, Professional Associations, Research networks

Association of Clinical Research Organizations (ACRO)

Associatie van Contract Research Organisaties in Nederland (ACRON)


Coalition for Epidemic Preparedness Innovation



European Federation of Pharmaceutical Industries and Associations (EFPIA)

European CRO Federation (EUCROF)

European Organisation for Research and Treatment of Cancer (EORTC)

Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)


Internation Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

International Pharmaceutical Federation (FIP)

Society for Clinical Data Management (SCDM)

Society for Clinical Research Sites

Society of Critical Care Medicine


Missing important links or found any broken links? Please use this form to report broken/missing links.

Clinical trials

Centre for Evidence-Based Medicine (CEBM)

EU Clinical Trials Register

National Institute for Health Research (NIHR)

Nederlands Trial Register

  • Trials for COVID
    The search function of NTR is not so accurate. Search results also shows trials not associated with COVID-19.


Trial Insights exclusive on



WHO International Clinical Trials Registry Platform (ICTRP)

  • WHO ICTRP Search Portal
    To view the COVID-19 trials worldwide, you must enter the search term ‘Covid-19’ in the search field.

Overige ontwikkelingen

Missing important links or found any broken links? Please use this form to report broken/missing links.

Biobanking, Patient Registries


CAPACITY registry


Lean European Open Survey on SARS-CoV-2 Infected Patients

Society of Critical Care Medicine (SCCM)

UKCRC Tissue Directory and Coordination Centre

Missing important links or found any broken links? Please use this form to report broken/missing links.


Artificial Intelligence/Kunstmatige Intelligentie

Biobanking and biospecimines

Clinical research resources

Clinical Research Organisations

Courses, Educative

Communication and digital solutions

Data management

Data Networks and research

Diagnostics, Genomics, Viral strains

Electronic Data Capturing

Castor has joined the global fight against the Coronavirus by making our research data capture platform available for free for all non-profit COVID19 research projects. We have developed ready for use eCRFs based on the WHO standard CRFs, to help researchers start their study or registry in less than an hour. The lack of quality data should not be the reason for a delay in finding a cure.
Derk Arts, 13 February 2020


Hacking Health


Research output

Social Sciences and Humanities, Expertise

SSH COVID-19 portal aims to consolidate and organize the SSH expertise across the Dutch universities in a publicly available national portal, ensuring fast and direct access to academic experts.
– Bron: SSH

Trackers & maps



Missing important links or found any broken links? Please use this form to report broken/missing links.


Crowdhelix Network

European Commission, H2020

Europen Coorperation in Science & Technology – COST

European Research Council

Funding opportunities

Funding support

Health Holland

Innovative Medicines Initiative

League of European Research Universities

Marie Skłodowska-Curie

Medical Research Council



UK Research and Innovation



Missing important links or found any broken links? Please use this form to report broken/missing links.

Other news

30 March 2020

29 March 2020

28 March 2020

27 March 2020

26 March 2020

25 March 2020

24 March 2020

23 March 2020

22 March 2020

21 March 2020

20 March 2020

19 March 2020

18 March 2020

17 March 2020

16 March 2020

The editors have become aware that some of the patients described in some of these manuscripts, sometimes with overlapping authorship, have been reported in more than 1 submission. This inclusion of the same patients in more than 1 report has not been clearly indicated in the submitted manuscripts. This is of concern and may represent a lapse in ethical standards of scientific reporting.
Editorial, JAMA, 16 March 2020, doi:10.1001/jama.2020.3980

15 March 2020

14 March 2020

13 March 2020

12 March 2020

10 March 2020

6 March 2020

4 March 2020

Overige berichtgeving mbt. AVG, Bescherming persoonsgegevens, Privacy

Missing important links or found any broken links? Please use this form to report broken/missing links.


Past webinars

Meer nieuws? Kijk ook eens op

Abonneren op de Nieuwsbrief voor Goede Onderzoekspraktijken

Kies voor een abonnement op de ‘Nieuwsbrief voor Goede Onderzoekspraktijken’ en blijf op de hoogte van actuele ontwikkelingen rond medisch-wetenschappelijk onderzoek met mensen, nieuwe wet- en regelgeving en gereviseerde richtlijnen! … Continue reading

Eerdere edities Nieuwsbrief voor Goede Onderzoekspraktijken

Op deze pagina vindt u een overzicht eerdere uitgaven van de Nieuwsbrief voor Goede Onderzoekspraktijken. … Continue reading

Leave a Reply

Your email address will not be published. Required fields are marked *

thirteen − eight =